Overview

A Study to Evaluate Safety and Tolerability of Multiple Doses of MEDI-546 in Adult Subjects With Scleroderma

Status:
Completed
Trial end date:
2011-07-01
Target enrollment:
Participant gender:
Summary
To evaluate the safety and tolerability of a multiple-dosed drug (MEDI-546) in adults with scleroderma.
Phase:
Phase 1
Details
Lead Sponsor:
MedImmune LLC
Treatments:
Antibodies, Monoclonal